Income Taxes - Schedule of Income Tax and Social Contribution Expense (Details) - USD ($) $ in Thousands |
12 Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|||||||
| Schedule of Income Tax and Social Contribution Expense [Abstract] | |||||||||
| Profit (loss) before taxes | $ 2,620,298 | $ 2,711,003 | $ (259,728) | ||||||
| Brazilian statutory corporate tax rate | (34.00%) | (34.00%) | (34.00%) | ||||||
| Expected tax benefit (expense) | $ (890,901) | $ (921,741) | $ 88,308 | ||||||
| Adjustments to reconcile taxable income tax expense (benefit): | |||||||||
| Share of profit of equity-accounted investees | 5,745 | 1,001 | 3,243 | ||||||
| Non-taxable tax benefits | [1] | 227,075 | 203,381 | 461,726 | |||||
| Difference of tax rates on taxable income from foreign subsidiaries | 75,755 | 167,945 | (16,299) | ||||||
| Transfer pricing adjustments | (34) | (952) | (12,265) | ||||||
| Profits taxed by-foreign jurisdictions | [2] | 152,352 | (203,735) | (203,986) | |||||
| Current year deferred taxes not recognized and deferred taxes recognized in prior years | (3,552) | (40,230) | (372,932) | ||||||
| Dividends paid abroad | (7,142) | ||||||||
| Non-taxable interest - Foreign subsidiaries | 21,299 | 671 | 140,284 | ||||||
| Donations and social programs expenses | [3] | (891) | (7,524) | ||||||
| Research and development benefit | 4,960 | 4,141 | |||||||
| SELIC interest on tax credits | 34,957 | 26,029 | 6,521 | ||||||
| Other permanent differences | (11,020) | 20,988 | 40,917 | ||||||
| Current and deferred income tax benefit (expense) | (390,506) | (743,393) | 127,993 | ||||||
| Current income tax | (450,240) | (870,474) | (69,460) | ||||||
| Deferred income tax | 59,734 | 127,081 | 197,453 | ||||||
| TOTAL INCOME TAXES | $ (390,506) | $ (743,393) | $ 127,993 | ||||||
| Effective income tax rate | (14.90%) | (27.42%) | 49.28% | ||||||
| |||||||||